Bank of Montreal’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bank of Montreal’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-650	Closed	-$5K	–	5529
2021 Q1	$5K	Sell	650 -2,760	-81%	-$23.8K	﹤0.01%	4691
2020 Q4	$26K	Buy	3,410 +2,398	+237%	+$13.7K	﹤0.01%	4309
2020 Q3	$6K	Sell	1,012 -101	-9%	-$500	﹤0.01%	4395
2020 Q2	$5K	Buy	+1,113	New	+$7.03K	﹤0.01%	4440
2019 Q3	–	Sell	-16	Closed	–	–	5123
2019 Q2	$0	Buy	+16	New	+$137	﹤0.01%	5192
2019 Q1	–	Sell	-151	Closed	-$1.56K	–	5002
2018 Q4	$2K	Buy	151 +79	+110%	+$1.74K	﹤0.01%	4481
2018 Q3	$2K	Hold	72	–	–	﹤0.01%	4456
2018 Q2	$2K	Buy	+72	New	+$1.71K	﹤0.01%	4463
2014 Q3	–	Sell	-128	Closed	-$2K	–	4593
2014 Q2	$2K	Buy	+128	New	+$1.67K	﹤0.01%	4535

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of Montreal's AVEO Position: Q2 2021 in Review

Bank of Montreal sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2021, closing a stake of 650 shares — an estimated $5K sold.

Bank of Montreal first reported a position in AVEO in Q2 2014 and held it in 9 quarters. The position peaked at $26K in Q4 2020. 63 funds tracked by Wall St. Rank hold AVEO as of Q2 2021.

Bank of Montreal reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 650 AVEO Pharmaceuticals, Inc. shares in Q2 2021, an estimated $5K.
Bank of Montreal first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2014 and held it in 9 quarters.
Bank of Montreal's AVEO Pharmaceuticals, Inc. position peaked at $26K in Q4 2020.
63 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.